| Announce Date | 01/20/2026 |
| EPS Normalized Actual | $1.26 (Beat by $0.07) |
| EPS GAAP Actual | $1.26 (Beat by $0.07) |
| Revenue Actual | $10.976B |
| Revenue Surprise | Beat by $10976M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 5.8 | 134.48 | 5.8 | 5.8 | 1 |
| Dec 2022 | 4.35174 | 179.23 | 4.35174 | 4.35174 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.26 | 1.26 | 10.976B | 36.42% | 10976M |
| FQ3 2025 (Sep 2025) | 1.22 | 1.22 | 9.807B | 72.47% | 9807M |
| FQ2 2025 (Jun 2025) | 1.11 | 1.11 | 7.604B | -42.03% | 7604M |
| FQ1 2025 (Mar 2025) | 1.03 | 1.03 | 10.35B | -1.1% | 10350M |
| FQ4 2024 (Dec 2024) | 1.02 | 1.02 | 6.979B | 3.55% | 6979M |
| FQ3 2024 (Sep 2024) | 1.1 | 1.1 | 2.7B | -159.26% | 2700M |
| FQ2 2024 (Jun 2024) | 1.03 | 1.03 | 10.8B | 33.88% | 10800M |
| FQ1 2024 (Mar 2024) | 0.85 | 0.85 | 10.464B | 31.76% | 10464M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | 1.5116 | -- | 1.5116 | 1.5116 | 1 |
| FQ2 2028 (Jun 2028) | 1.4863 | -- | 1.4863 | 1.4863 | 1 |
| FQ1 2028 (Mar 2028) | 1.3284 | -- | 1.3284 | 1.3284 | 1 |
| FQ4 2027 (Dec 2027) | 1.43695 | -- | 1.43695 | 1.43695 | 1 |
| FQ3 2027 (Sep 2027) | 1.40273 | -- | 1.40273 | 1.40273 | 1 |
| FQ2 2027 (Jun 2027) | 1.33853 | -- | 1.33853 | 1.33853 | 1 |
| FQ1 2027 (Mar 2027) | 1.18723 | -- | 1.18723 | 1.18723 | 1 |
| FQ4 2026 (Dec 2026) | 1.30104 | 3.15 | 1.30104 | 1.30104 | 1 |
| FQ3 2026 (Sep 2026) | 1.24628 | 2.11 | 1.24628 | 1.24628 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Sep 2028) | -1.42B | -- | -1.42B | -1.42B | 0 |
| FQ2 2028 (Jun 2028) | -1.36B | -- | -1.36B | -1.36B | 0 |
| FQ1 2028 (Mar 2028) | -1.31B | -- | -1.31B | -1.31B | 0 |
| FQ4 2027 (Dec 2027) | 7.95B | -- | 7.95B | 7.95B | 1 |
| FQ3 2027 (Sep 2027) | 7.92B | -- | 7.92B | 7.92B | 1 |
| FQ2 2027 (Jun 2027) | 7.81B | -- | 7.81B | 7.81B | 1 |
| FQ1 2027 (Mar 2027) | 7.57B | -- | 7.57B | 7.57B | 1 |
| FQ4 2026 (Dec 2026) | 7.65B | -43.4 | 7.65B | 7.65B | 1 |
| FQ3 2026 (Sep 2026) | 7.6B | -29.03 | 7.6B | 7.6B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 1.26 | 1.26 | 100% | |
| FQ3 2025 (Sep 2025) | 1.22 | 1.22 | 100% | |
| FQ2 2025 (Jun 2025) | 1.11 | 1.11 | 100% | |
| FQ1 2025 (Mar 2025) | 1.03 | 1.03 | 100% | |
| FQ4 2024 (Dec 2024) | 1.02 | 1.02 | 100% | |
| FQ3 2024 (Sep 2024) | 1.1 | 1.1 | 100% | |
| FQ2 2024 (Jun 2024) | 1.03 | 1.03 | 100% | |
| FQ1 2024 (Mar 2024) | 0.85 | 0.85 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0B | $10.98B | $10976M | 100% |
| FQ3 2025 (Sep 2025) | $0B | $9.81B | $9807M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $7.6B | $7604M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $10.35B | $10350M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $6.98B | $6979M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $2.7B | $2700M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $10.8B | $10800M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $10.46B | $10464M | 100% |